Summary of Purpose
This study evaluates the use of the investigational drug BIIB093 versus placebo in patients with a large hemispheric infarction.Read More →
The following dates are available for this trial. Trial information last updated on 20 March 2018.
|29 Jun 2018||12 Jul 2016||28 Sep 2020||28 Jun 2021||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Interventions See All
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
- Remedy Pharmaceuticals, Inc.
- US Biogen Medical Information